Literature DB >> 31797155

Failure to complete treatment for latent tuberculosis infection in Portugal, 2013-2017: geographic-, sociodemographic-, and medical-associated factors.

Alexis Sentís1,2,3,4,5, Paula Vasconcelos1,2, Rita Sá Machado1,2, Joan A Caylà6, Mònica Guxens3,4,5,7, Vasco Peixoto1,2, Raquel Duarte1,8,9,10, Isabel Carvalho1, Carlos Carvalho11,12,13.   

Abstract

There is conflicting evidence about factors associated with failure to complete treatment (FCT) for latent tuberculosis infection (LTBI). We aim to identify the geographic, sociodemographic, and medical factors associated with FCT in Portugal, highlighting the two main metropolitan areas of Porto and Lisbon. We performed a retrospective cohort study including LTBI patients that started treatment in Portugal between 2013 and 2017. We calculated adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) using multivariable logistic regression to identify geographic, sociodemographic, and medical factors associated with FCT. Data on completion of treatment were available for 15,478 of 17,144 patients (90.3%). Of those, 2132 (13.8%) failed to complete treatment. Factors associated with FCT were being older than 15 years (aOR, 1.65 (95% CI = 1.34-2.05) for those aged 16 to 29), being born abroad (aOR, 2.04 (95% CI = 1.19-3.50) for Asia; aOR, 1.57 (95% CI = 1.24-1.98) for Africa), having a chronic disease (aOR, 1.29 (95% CI = 1.04-1.60)), alcohol abuse (aOR, 2.24 (95% CI = 1.73-2.90)), and being intravenous drug user (aOR, 1.68 (95% CI = 1.05-2.68)). Three-month course treatment with isoniazid plus rifampicin was associated with decreased FCT when compared with 6- or 9-month courses of isoniazid-only (aOR, 0.59 (95% CI = 0.45-0.77)). In Lisbon metropolitan area, being born in Africa, and in Porto metropolitan area, alcohol abusing and being intravenous drug user were distinctive factors associated with FCT. Sociodemographic and medical factors associated with FCT may vary by geographical area and should be taken into account when planning interventions to improve LTBI treatment outcomes. This study reinforces that shorter course treatment for LTBI might reduce FCT.

Entities:  

Keywords:  Adherence; Associated factors; Latent tuberculosis infection; Non-completion; Risk factors; Treatment

Year:  2019        PMID: 31797155     DOI: 10.1007/s10096-019-03765-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Comparative Study Between Tuberculosis Incidence Rates in the Two Largest Metropolitan Areas of Portugal.

Authors:  Mafalda Felgueiras; Sara Cerqueira; Rita Gaio; Óscar Felgueiras; Raquel Duarte
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2018-06-06       Impact factor: 4.872

2.  Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.

Authors:  Dick Menzies; Menonli Adjobimey; Rovina Ruslami; Anete Trajman; Oumou Sow; Heejin Kim; Joseph Obeng Baah; Guy B Marks; Richard Long; Vernon Hoeppner; Kevin Elwood; Hamdan Al-Jahdali; Martin Gninafon; Lika Apriani; Raspati C Koesoemadinata; Afranio Kritski; Valeria Rolla; Boubacar Bah; Alioune Camara; Isaac Boakye; Victoria J Cook; Hazel Goldberg; Chantal Valiquette; Karen Hornby; Marie-Josée Dion; Pei-Zhi Li; Philip C Hill; Kevin Schwartzman; Andrea Benedetti
Journal:  N Engl J Med       Date:  2018-08-02       Impact factor: 91.245

3.  The prognosis of a positive tuberculin reaction in childhood and adolescence.

Authors:  G W Comstock; V T Livesay; S F Woolpert
Journal:  Am J Epidemiol       Date:  1974-02       Impact factor: 4.897

Review 4.  Preventive therapy for latent tuberculosis infection-the promise and the challenges.

Authors:  G J Fox; C C Dobler; B J Marais; J T Denholm
Journal:  Int J Infect Dis       Date:  2016-11-18       Impact factor: 3.623

5.  Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.

Authors:  Robert Belknap; David Holland; Pei-Jean Feng; Joan-Pau Millet; Joan A Caylà; Neil A Martinson; Alicia Wright; Michael P Chen; Ruth N Moro; Nigel A Scott; Bert Arevalo; José M Miró; Margarita E Villarino; Marc Weiner; Andrey S Borisov
Journal:  Ann Intern Med       Date:  2017-11-07       Impact factor: 25.391

6.  Use of isoniazid for latent tuberculosis infection in a public health clinic.

Authors:  Philip A LoBue; Kathleen S Moser
Journal:  Am J Respir Crit Care Med       Date:  2003-05-13       Impact factor: 21.405

7.  Geographic information system-based screening for TB, HIV, and syphilis (GIS-THIS): a cross-sectional study.

Authors:  Neela D Goswami; Emily J Hecker; Carter Vickery; Marshall A Ahearn; Gary M Cox; David P Holland; Susanna Naggie; Carla Piedrahita; Ann Mosher; Yvonne Torres; Brianna L Norton; Sujit Suchindran; Paul H Park; Debbie Turner; Jason E Stout
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

8.  A spatial, social and environmental study of tuberculosis in China using statistical and GIS technology.

Authors:  Wenyi Sun; Jianhua Gong; Jieping Zhou; Yanlin Zhao; Junxiang Tan; Abdoul Nasser Ibrahim; Yang Zhou
Journal:  Int J Environ Res Public Health       Date:  2015-01-27       Impact factor: 3.390

9.  Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study.

Authors:  Chin-Chung Shu; Chia-Lin Hsu; Chih-Yuan Lee; Jann-Yuan Wang; Vin-Cent Wu; Feng-Jung Yang; Jann-Tay Wang; Chong-Jen Yu; Li-Na Lee
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

Review 10.  Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.

Authors:  Anke L Stuurman; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anouk M Oordt-Speets; Andreas Sandgren; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-06-08       Impact factor: 3.090

View more
  1 in total

Review 1.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.